B. Riley Weighs in on Joint's FY2025 Earnings (NASDAQ:JYNT)

The Joint Corp. (NASDAQ:JYNT - Free Report) - Research analysts at B. Riley raised their FY2025 EPS estimates for Joint in a report released on Friday, November 8th. B. Riley analyst J. Van. Sinderen now expects that the company will post earnings per share of $0.62 for the year, up from their previous forecast of $0.58. The consensus estimate for Joint's current full-year earnings is $0.13 per share. B. Riley also issued estimates for Joint's FY2026 earnings at $0.60 EPS.

JYNT has been the topic of a number of other reports. Roth Mkm lowered their price objective on shares of Joint from $16.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday. StockNews.com downgraded Joint from a "buy" rating to a "hold" rating in a report on Thursday.

Joint Price Performance

Shares of JYNT traded up $0.97 during mid-day trading on Monday, reaching $12.58. 81,357 shares of the company's stock were exchanged, compared to its average volume of 68,250. The stock has a market capitalization of $188.70 million, a PE ratio of -10.66 and a beta of 1.57. The business's fifty day simple moving average is $11.26 and its 200-day simple moving average is $12.97. Joint has a 52-week low of $8.26 and a 52-week high of $17.82.

Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The company had revenue of $30.26 million during the quarter, compared to analysts' expectations of $29.65 million. Joint had a negative net margin of 13.95% and a positive return on equity of 7.89%.

Institutional Trading of Joint

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. raised its position in shares of Joint by 8.9% in the 1st quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company's stock valued at $1,177,000 after purchasing an additional 7,375 shares in the last quarter. First Foundation Advisors raised its position in shares of Joint by 18.8% in the 1st quarter. First Foundation Advisors now owns 209,301 shares of the company's stock valued at $2,733,000 after purchasing an additional 33,104 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Joint by 5.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company's stock valued at $229,000 after acquiring an additional 837 shares in the last quarter. Ancora Advisors LLC raised its position in shares of Joint by 105.0% during the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company's stock valued at $1,296,000 after acquiring an additional 50,815 shares in the last quarter. Finally, Avondale Wealth Management raised its position in shares of Joint by 15.8% during the 2nd quarter. Avondale Wealth Management now owns 22,000 shares of the company's stock valued at $309,000 after acquiring an additional 3,000 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company's stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.